India to Guatemala: Sunitinib Export Trade Route
India has recorded 4 verified shipments of Sunitinib exported to Guatemala, representing a combined trade value of $527.0K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $131.8K USD. The leading Indian exporter is CAPLIN POINT LABORATORIES LIMITED, which accounts for 100% of total export value with 4 shipments worth $527.0K USD. On the buying side, NUEVOS ETICOS NEOETHICALS S A is the largest importer in Guatemala with $527.0K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Guatemala Sunitinib corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $527.0K USD. The route is dominated by CAPLIN POINT LABORATORIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's sunitinib manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $131.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with sunitinib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 10.1%, placing it at rank #12 among India's top sunitinib export destinations globally.
On the import side, key buyers of Indian sunitinib in Guatemala include NUEVOS ETICOS NEOETHICALS S A. NUEVOS ETICOS NEOETHICALS S A is the single largest importer with 4 shipments valued at $527.0K USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ1
- Primary modeSea freight
- Top portCHENNAI AIR
Market Position
- Global rank#12
- Annual growth+10.1%
- Demand growth+10.8%
- Regulatory ease88/100
Top 10 Indian Sunitinib Exporters to Guatemala
Showing top 10 of 1 Indian suppliers exporting Sunitinib to Guatemala, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CAPLIN POINT LABORATORIES LIMITED Avg $131.8K per shipment | 4 | $527.0K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting sunitinib to Guatemala, ranked by total trade value. The listed exporters are: CAPLIN POINT LABORATORIES LIMITED. CAPLIN POINT LABORATORIES LIMITED is the dominant supplier with 4 shipments worth $527.0K USD, giving it a 100% market share.
Top 10 Sunitinib Importers in Guatemala
Showing top 10 of 1 known buyers in Guatemala receiving Sunitinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sunitinib in Guatemala include NUEVOS ETICOS NEOETHICALS S A. The largest importer is NUEVOS ETICOS NEOETHICALS S A, accounting for $527.0K USD across 4 shipments — representing 100% of all sunitinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NUEVOS ETICOS NEOETHICALS S A | 4 | $527.0K | 100.0% |
Top 10 Sunitinib Formulations Imported by Guatemala
Showing top 10 of 2 product formulations shipped on the India to Guatemala Sunitinib route, ranked by trade value
Guatemala imports a wide range of sunitinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SUNITINIB CAPSULES 50MG — accounts for $516.8K USD across 3 shipments. A total of 2 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUNITINIB CAPSULES 50MG | 3 | $516.8K | 98.1% |
| 2 | SUNITINIB CAPSULES 12.5MG | 1 | $10.2K | 1.9% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
CHENNAI AIR handles the highest volume with 4 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's sunitinib exports to Guatemala are driven primarily by a handful of large-scale manufacturers. CAPLIN POINT LABORATORIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Guatemala benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CAPLIN POINT LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $131.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as sunitinib capsules 12.5mg, suggesting that buyers in Guatemala tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NUEVOS ETICOS NEOETHICALS S A is the largest importer with 4 shipments worth $527.0K USD — representing 100% of all sunitinib imports from India on this route.
Route Statistics
- Trade Volume
- $527.0K
- Avg. Shipment
- $131.8K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~25 days
- Annual Growth
- +10.1%
Other Sunitinib Routes
Unlock the Full India to Guatemala Sunitinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 4 shipments on this route.
Frequently Asked Questions — India to Guatemala Sunitinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sunitinib to Guatemala?
The leading Indian exporters of Sunitinib to Guatemala are CAPLIN POINT LABORATORIES LIMITED. CAPLIN POINT LABORATORIES LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Sunitinib exports from India to Guatemala?
India exports Sunitinib to Guatemala worth approximately $527.0K USD across 4 recorded shipments. The average value per shipment is $131.8K USD.
Q Which ports does India use to ship Sunitinib to Guatemala?
The most active port of origin is CHENNAI AIR with 4 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Guatemala for Sunitinib?
The average transit time for Sunitinib shipments from India to Guatemala is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Guatemala Sunitinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 10.1% with demand growth tracking at 10.8%. The route is ranked #12 among India's top Sunitinib export destinations globally.
Q How many suppliers are active on the India to Guatemala Sunitinib route?
There are currently 1 active Indian suppliers exporting Sunitinib to Guatemala. The market is moderately concentrated with CAPLIN POINT LABORATORIES LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Sunitinib from India in Guatemala?
The leading importers of Indian Sunitinib in Guatemala include NUEVOS ETICOS NEOETHICALS S A. NUEVOS ETICOS NEOETHICALS S A is the largest buyer with 4 shipments worth $527.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Guatemala export trade corridor identified from Indian Customs (DGFT) records for Sunitinib.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Guatemala matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 4 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists